Emerging research from BrightFocus Foundation and other leading experts is shedding light on how lifestyle-based "biohacks"—particularly intermittent fasting, the fasting-mimicking diet (FMD), and targeted nutritional strategies—may play a powerful role in maintaining cognitive function and potentially delaying the onset of Alzheimer’s disease.
Unlike basic calorie restriction, intermittent fasting and FMD trigger a metabolic switch from using glucose to ketones for energy—a state known as ketosis. This shift enhances cellular resilience by stimulating repair pathways, reducing inflammation, and promoting the production of brain-derived neurotrophic factor (BDNF), a molecule critical for neuroplasticity and memory formation.
According to Dr. Mark Mattson from the National Institute on Aging, fasting can increase ketone levels up to 20 times more than a ketogenic diet. These elevated ketone levels may better support brain function and offer stronger neuroprotective effects compared to traditional low-carb dietary approaches.
BrightFocus grantees are developing new imaging techniques to explore how the brain utilizes ketones versus glucose in individuals with or at risk for Alzheimer’s disease. These findings could uncover novel pathways for treatment and prevention, particularly for those with genetic predispositions.
Although the ketogenic diet shares metabolic similarities with fasting, it has been associated with side effects such as gastrointestinal issues, weight loss (which can be problematic in aging populations), and nutrient deficiencies. Exogenous ketone supplementation is currently being explored as a safer alternative that mimics the benefits of fasting without the dietary constraints.
Pioneered by Dr. Valter Longo of the USC Longevity Institute, the longevity diet emphasizes a plant-forward, nutrient-rich approach to eating that integrates cycles of fasting or FMD. This diet includes:
This style of eating has been linked to reduced cognitive decline and lower Alzheimer’s risk in populations such as centenarians in Okinawa and Loma Linda.
In animal studies, periodic FMD cycles led to reduced brain inflammation, fewer Alzheimer’s biomarkers (amyloid plaques and tau tangles), and enhanced cognitive performance. Early human data suggests this 5-day-a-month approach is safe for patients with early-stage Alzheimer’s, though rigorous clinical trials are still ongoing.
While the benefits are promising, fasting is not universally safe. People on certain medications, those with diabetes, or individuals with a history of disordered eating should only consider fasting under strict medical supervision. Side effects like fatigue, nausea, and dizziness are also possible.
Biohacking the brain through fasting and diet shows significant potential but must be approached with nuance and personalized guidance. The most sustainable and accessible path to cognitive health may still lie in:
Genetic testing for those with a family history of Alzheimer’s may also help guide dietary and lifestyle strategies.
Source:
Biohacking Brain Health: Research Exploring Fasting and Diet Changes Shows Promise in Delaying Alzheimer’s Disease, Improving Cognition – BrightFocus Foundation (https://www.brightfocus.org/resource/biohacking-brain-health-research-exploring-fasting-and-diet-changes-shows-promise-in-delaying-alzheimers-disease-improving-cognition/).
tukaj je besedilo
tukaj je besedilo
tukaj je besedilo
tukaj je besedilo
tukaj je besedilo
tukaj je besedilo
tukaj je besedilo
tukaj je besedilo
tukaj je besedilo
